MannKind Corporation (NASDAQ:MNKD) traded at $5.19 at close of the session on Tuesday, 01/24/23, made an upward move of 6.79% on its previous day’s price.
Looking at the stock we see that its previous close was $4.86 and the beta (5Y monthly) reads 1.70 with the day’s price range being $4.77 – $5.2199. In terms of its 52-week price range, MNKD has a high of $5.47 and a low of $2.49. The company’s stock has lost about -0.19% over that past 30 days.
MannKind Corporation has a market cap of $1.30 billion and is expected to release its quarterly earnings report on Feb 22, 2023 – Feb 27, 2023. Estimates by analysts give the company expected earnings per share (EPS) of -$0.09, with the EPS growth for the year raised at -$0.36 for 2022 and -$0.13 for next year. These figures represent -12.50% and 63.90% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $25.47 million, with a low of $22.3 million and a high of $27.55 million. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2022 is expected to hit $90.34 million, or 19.70% up from figures reported last year.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the MNKD stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy. Long term indicators on average place the stock in the category of 100% Buy.
Looking further, we note the current price level is 4.87% off its SMA20 and 9.72% from its 50-day simple moving average. The RSI (14) is pointing at 59.95 while the volatility over the past week is 5.00% and jumps to 5.15% over the past one month. The beta value is 1.65, while the average true range (ATR) is currently pointing at 0.26.
Let’s briefly compare MannKind Corporation (MNKD) stock to its peers. We find that current price change of 6.79% and 36.94% over the past 12 months for MNKD competes that of Eli Lilly and Company (LLY), which has seen its stock price rise 1.22% in the last trading session and was 42.51% over the last one year. Another of its peers Pfizer Inc. (PFE) has dropped -0.60% previous session, and was -15.31% down over the past year, while Novo Nordisk A/S (NVO) was also down -0.84% in the last session, while its price remained in the green at 46.71% over the same period.. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial were at -0.07% and 0.31%, respectively, at close of the trading.
Coming back to MannKind Corporation (NASDAQ:MNKD), we note that the average 3-month trading volume was 4.47 million, while that of the preceding 10-day period stands at 3.77 million. Current shares outstanding are 259.30 million.
The insiders hold 2.20% of the company’s shares while institutions hold 50.30%. The data shows that short shares as of Oct 13, 2022, stood at 35.9 million at a short ratio of 7. This represents a 13.95% short interest in shares outstanding on Oct 13, 2022. Shares short rose in October from the previous month at 31.43 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -1.52% down in year-to-date price movement.